secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-327097
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio enters $20.1M private placement with potential second $20.1M tranche tied to INB-619 milestone
--------------------------------------------------------------------------------

- Initial closing: 5,127,029 shares at $1.38 and 9,452,677 pre-funded warrants for ~$20.1M gross.
- Second closing up to 14.6M shares/warrants (~$20.1M) conditional on INB-619 milestone and stock price hitting $2.76 or waiver.
- Investors granted pre-emptive rights to participate in subsequent equity financings up to 200% of their investment.
- Company to file resale registration statement within 30 days of each closing, with liquidated damages for delays.
- Private placement exempt from registration; purchasers are qualified institutional buyers or accredited investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525327097/0001193125-25-327097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312525327097/d145007d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-327097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer